DE68927104T2 - Gentherapie unter verwendung von genschmelzen für genetische und erworbene störungen - Google Patents

Gentherapie unter verwendung von genschmelzen für genetische und erworbene störungen

Info

Publication number
DE68927104T2
DE68927104T2 DE68927104T DE68927104T DE68927104T2 DE 68927104 T2 DE68927104 T2 DE 68927104T2 DE 68927104 T DE68927104 T DE 68927104T DE 68927104 T DE68927104 T DE 68927104T DE 68927104 T2 DE68927104 T2 DE 68927104T2
Authority
DE
Germany
Prior art keywords
gene
genetic
melts
acquired disorders
gene therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE68927104T
Other languages
English (en)
Other versions
DE68927104D1 (de
Inventor
Ira Pastan
Michael Gottesman
Ursula A Germann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Application granted granted Critical
Publication of DE68927104D1 publication Critical patent/DE68927104D1/de
Publication of DE68927104T2 publication Critical patent/DE68927104T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DE68927104T 1988-06-03 1989-06-05 Gentherapie unter verwendung von genschmelzen für genetische und erworbene störungen Expired - Lifetime DE68927104T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20278388A 1988-06-03 1988-06-03
PCT/US1989/002450 WO1989012109A1 (en) 1988-06-03 1989-06-05 Gene therapy using gene fusions for genetic or acquired disorders

Publications (2)

Publication Number Publication Date
DE68927104D1 DE68927104D1 (de) 1996-10-10
DE68927104T2 true DE68927104T2 (de) 1997-03-06

Family

ID=22751243

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68927104T Expired - Lifetime DE68927104T2 (de) 1988-06-03 1989-06-05 Gentherapie unter verwendung von genschmelzen für genetische und erworbene störungen

Country Status (8)

Country Link
EP (1) EP0420911B1 (de)
JP (1) JP2949440B2 (de)
AT (1) ATE142269T1 (de)
AU (1) AU634162B2 (de)
CA (1) CA1339654C (de)
DE (1) DE68927104T2 (de)
IL (1) IL90514A (de)
WO (1) WO1989012109A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU637986B2 (en) * 1988-10-21 1993-06-17 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Transgenic animals for testing multidrug resistance
US5858784A (en) * 1991-12-17 1999-01-12 The Regents Of The University Of California Expression of cloned genes in the lung by aerosol- and liposome-based delivery
US6627615B1 (en) 1991-12-17 2003-09-30 The Regents Of The University Of California Methods and compositions for in vivo gene therapy
US5756353A (en) * 1991-12-17 1998-05-26 The Regents Of The University Of California Expression of cloned genes in the lung by aerosol-and liposome-based delivery
US6806084B1 (en) 1992-06-04 2004-10-19 The Regents Of The University Of California Methods for compositions for in vivo gene delivery
EP0646178A1 (de) * 1992-06-04 1995-04-05 The Regents Of The University Of California Expression kassette mit im säugetier wirt funktionnellen regulator sequenzen
DE4238778C2 (de) * 1992-11-12 1995-11-02 Max Delbrueck Centrum Vektor zur Expression von therapeutisch relevanten Genen
US5968735A (en) * 1992-11-12 1999-10-19 Max Delbruck-Centrum Fur Molekular Medizin Berlin Vector for the expression of therapy-relevant genes
US6344445B1 (en) 1995-10-19 2002-02-05 Cantab Pharmaceutical Research Limited Herpes virus vectors and their uses
GB9622500D0 (en) 1996-10-29 1997-01-08 Oxford Biomedica Ltd Therapeutic gene
GB2333527B (en) * 1996-10-29 2001-05-02 Oxford Biomedica Ltd Therapeutic gene
US6924123B2 (en) 1996-10-29 2005-08-02 Oxford Biomedica (Uk) Limited Lentiviral LTR-deleted vector
PL3461888T3 (pl) 2012-09-11 2020-12-14 Corning Incorporated Ulegające zużyciu krioprezerwowane komórki wykazujące przejściową nadekspresję genu(-ów) kodującego(-ych) białko(-a) transportera leku i/lub enzym(y) metabolizujący(-e) lek

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU197349B (en) * 1982-05-25 1989-03-28 Lilly Co Eli Process for producing cloning vectors usable for the expression of growth hormones
DE3715033A1 (de) * 1987-05-06 1988-11-17 Hoechst Ag Verfahren zur isolierung von fusionsproteinen
AU637986B2 (en) * 1988-10-21 1993-06-17 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Transgenic animals for testing multidrug resistance
DK0478696T3 (da) * 1989-06-23 1995-06-26 Us Health Effektiv fremgangsmåde til identificerbar udtrykkelse af ikke-selekterbare gener

Also Published As

Publication number Publication date
JP2949440B2 (ja) 1999-09-13
EP0420911A1 (de) 1991-04-10
AU3778889A (en) 1990-01-05
AU634162B2 (en) 1993-02-18
WO1989012109A1 (en) 1989-12-14
CA1339654C (en) 1998-02-03
IL90514A (en) 1995-10-31
EP0420911A4 (en) 1991-11-13
ATE142269T1 (de) 1996-09-15
DE68927104D1 (de) 1996-10-10
EP0420911B1 (de) 1996-09-04
JPH03505818A (ja) 1991-12-19

Similar Documents

Publication Publication Date Title
ATE142269T1 (de) Gentherapie unter verwendung von genschmelzen für genetische und erworbene störungen
DK309387A (da) Humant erythropoietin-gen samt expression deraf i transficerede celler
DE3585953D1 (de) Dna-fragmente, expressionsvektoren, proteine, wirte und verfahren zur herstellung der proteine.
IL118201A0 (en) Erythropoietin free of animal proteins processes for production and use thereof
NZ221119A (en) Proteins with factor viii activity produced by microorganisms produced by genetic engineering
FI893542A (fi) Entsyymielektrodit ja menetelmä niiden valmistamiseksi
AU4159185A (en) Method of inhibiting binding of von willebrand factor to human platelets and inducing interaction of platelets with vessel walls
ATE117375T1 (de) Transduktionsveränderte fibroblasten und ihre anwendung.
ATE391175T1 (de) Multidrug resistenz gen
DK100985A (da) Dna, der koder for human tumornecrosefaktor, samt humant tumornecrosefaktor-polypeptid og fremgangsmaader til fremstilling heraf
NZ334546A (en) Erythropoietin receptor agonist and use in the treatment of hematopoietic disorders
DE3881063D1 (de) Tdma-system und methode geschickt zur individuellen kontrolle der elektrischen staerke von data-bursts.
DE3874495T2 (de) Elektrodenkatalysator und dessen herstellungsverfahren.
DE3673112D1 (de) Elektroden zur verwendung bei elektrochemischen verfahren und herstellung.
DE3861520D1 (de) Spannungsregler und spannungsstabilisator.
DE68914412D1 (de) Methode, System und Apparat zur Züchtung von Zellen.
ATE75778T1 (de) Immunosuppressionsfaktor.
DE3576361D1 (de) Rekombinante dna, damit transformierter mikroorganismus, und verfahren zur herstellung von menschlicher cu-zn superoxiddismutase unter verwendung des transformierten mikroorganismus.
DE68911297T2 (de) Heparin bindende proteine, dafür kodierende dna, verfahren zu ihrer herstellung sowie sie enthaltende therapeutische präparate.
JPS6430588A (en) Foreign dna developing promoter n methylotroph bacteria, its production and use
NO875479L (no) Fremgangsmaate for setting av elektroder i elektrolyseceller.
DK125289A (da) Dna-struktur, omfattende en aktivator-stimuleret promotor til udtrykkelse af et oensket protein, samt fremgangsmaade til udtrykkelse af proteinet ved hjaelp af dna-strukturen
DK502885D0 (da) Fremgangsmaade samt apparat til kontinuerlig koagulering
DE3888715T2 (de) Reg-Gen und dadurch kodiertes Protein.
NO862613L (no) Nye polypeptider med vekstfaktoraktivitet og nukleinsyresekvenser som koder for polypeptidene.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition